Loading...
Loading...
Application UK00914779458 · Expired

| Application Number | UK00914779458 |
| Status | Expired |
| Owner | Molecular Health GmbH |
| Filed | 2015-11-09 |
| Registered | 2016-06-10 |
| Renewal Due | 2025-11-09 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
ENGINEUS has a current status of Expired.
Colour Claimed : Dark Blue; Light Blue.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Consulting and research services to employers in the field of offering medical and health care diagnostic and/or treatment support programs to employees and family members and/or domestic partners of employees as an employee benefit.
Administration and provision of programs and services for payment and/or reimbursement of medical and health care diagnostic and/or treatment support programs to employees and family members and/or domestic partners of employees as an employee benefit.
Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; providing access to computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing access to software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing access to database containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research tor medical diagnostic; and/or treatment purposes.
Consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and/or pharmaceuticals and pharmaceutics\\ safety for Scientific research purposes; consulting and research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data, and/or molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; designing and/or developing and/or providing use of searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and/or medical and/or health information or records, molecular test results and/or patient specific data about or relating to humans for scientific research purposes; designing and/or developing and/or providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development; designing and/or developing and/or providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; research or consulting services featuring software under a software as a Service (SaaS) model for enabling the retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research and/or health and/or medical information, records or data for medical, diagnostic and/or treatment and/or drug safety research and/or drug or pharmaceuticals or other treatment discovery, research and/or development purposes; provision of mobile applications for mobile devices, such as eg smart phones and tablets, and web applications accessible through the Internet in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; research services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of computer software and/or algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and/or treatment purposes; providing use of software and/or algorithms for retrieval, integration, correlation, analysis and/or interpretation of genomic data, sequencing data and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing information in the fields of life sciences, biotechnology, bioinformatics.
Consulting services for the retrieval, integration, correlation, analysis and/or interpretation of genomic, sequencing and/or molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and/or medical and/or health information, records or data, and/or patient specific data, molecular test results, data from clinical studies, and/or scientific research for medical diagnostic and/or treatment purposes; providing use of databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and/or medical or health information or records about or relating to humans and/or patient specific data, molecular test results, and/or scientific research for medical diagnostic and/or treatment purposes; consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical information, including information about drug safety and/or drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'ENGINEUS' is a expired trademark on the UK IPO register, owned by Molecular Health GmbH. The application (UK00914779458) was filed on 9 November 2015 and registered on 10 June 2016. The registration is set to expire on 9 November 2025.
This mark is recorded under multiple classes: Class 35 (advertising, business management & retail services); Class 36 (insurance & financial services); Class 38 (telecommunications services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services), specifically covering: Colour Claimed : Dark Blue; Light Blue.
The trademark is represented by PATENTANWÄLTE ISENBRUCK BÖSL HÖRSCHLER PARTG MBB.
UK trademark UK00914779458 for the mark 'ENGINEUS' in Class 35, 36, 38, 42, 44 is recorded on the UK IPO register as owned by Molecular Health GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00914779458 for the mark 'ENGINEUS' as expired.
UK trademark UK00914779458 for the mark 'ENGINEUS' is recorded in Class 35 (advertising, business management & retail services); Class 36 (insurance & financial services); Class 38 (telecommunications services); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 35: Consulting and research services to employers in the field of offering medical and health care diagnostic and/or treatment support programs to employees and family members and/or domestic partners of employees as an employee benefit. | Class 36: Administration and provision of programs and services for pay…
UK trademark UK00914779458 for the mark 'ENGINEUS' was filed at the UK IPO on 9 November 2015 and registered on 10 June 2016.
UK trademark UK00914779458 for the mark 'ENGINEUS' is currently recorded as valid until 9 November 2025, at which point it will need to be renewed with the UK IPO to remain in force.
PATENTANWÄLTE ISENBRUCK BÖSL HÖRSCHLER PARTG MBB is listed as the attorney / representative of record for UK trademark UK00914779458 for the mark 'ENGINEUS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "ENGINEUS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ENGINEUSSame applicant | 86815589 | 602 | 2015-11-10 |
| ENGINEUSSame applicant | 86815598 | 602 | 2015-11-10 |
| ENGINEUSSame applicant | 86815607 | 602 | 2015-11-10 |
| ENGINEUS THE HEALTHCARE DECISION ENGINESame applicant | 86815632 | 602 | 2015-11-10 |
| ENGINEUS THE HEALTHCARE DECISION ENGINESame applicant | 86815690 | 602 | 2015-11-10 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.